Humana Financial Statements
NYSE: HUMHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:02 PM ET · Delayed 15 min
Humana revenue and earnings
In fiscal 2025, Humana generated $129.66 billion in revenue, up 10.1% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $1.19 billion (-1.6% year over year), for a net margin of 0.9% versus a median of 3.0% in the prior 5 years. Operating margin was 2.1%.
Diluted earnings per share came in at $9.84, down from $9.98. Over the last 5 fiscal years, HUM's revenue has grown at a 10.9% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Humana income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 129.66B | 117.76B | 106.37B | 92.87B | 83.06B | 77.16B | 64.89B | 56.91B | 53.77B | 54.38B |
| Revenue growth (YoY) | +10.11% | +10.70% | +14.54% | +11.81% | +7.66% | +18.90% | +14.01% | +5.85% | -1.13% | +0.17% |
| Operating Expenses | 126.96B | 115.20B | 102.36B | 89.07B | 79.92B | 72.17B | 61.70B | 53.81B | 49.51B | 52.64B |
| Selling, General & Admin | 15.45B | 13.70B | 13.19B | 12.67B | 10.12B | 10.05B | 7.38B | 7.53B | 6.57B | 7.17B |
| Operating Income | 2.70B | 2.56B | 4.01B | 3.80B | 3.15B | 4.99B | 3.19B | 3.10B | 4.26B | 1.74B |
| Interest Expense | 631.00M | 660.00M | 493.00M | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M | 242.00M | 189.00M |
| Other Income (Expense) | -451.00M | -181.00M | -137.00M | -68.00M | 532.00M | -103.00M | 506.00M | -33.00M | 0 | 0 |
| Pretax Income | 1.44B | 1.62B | 3.33B | 3.56B | 3.42B | 4.67B | 3.47B | 2.07B | 4.02B | 1.55B |
| Income Tax | 250.00M | 413.00M | 836.00M | 762.00M | 485.00M | 1.31B | 763.00M | 391.00M | 1.57B | 938.00M |
| Net Income | 1.19B | 1.21B | 2.49B | 2.81B | 2.93B | 3.37B | 2.71B | 1.68B | 2.45B | 614.00M |
| Net Income growth (YoY) | -1.57% | -51.51% | -11.30% | -4.33% | -12.89% | +24.38% | +60.84% | -31.25% | +298.70% | -51.88% |
| EPS (Basic) | 9.87 | 10.01 | 20.09 | 22.20 | 22.79 | 25.47 | 20.20 | 12.24 | 16.94 | 4.11 |
| EPS (Diluted) | 9.84 | 9.98 | 20.00 | 22.08 | 22.67 | 25.31 | 20.10 | 12.16 | 16.81 | 4.07 |
| Shares Outstanding (Basic) | 120.45M | 120.57M | 123.87M | 126.42M | 128.69M | 132.20M | 134.06M | 137.49M | 144.49M | 149.38M |
| Shares Outstanding (Diluted) | 120.83M | 120.87M | 124.44M | 127.09M | 129.40M | 133.01M | 134.73M | 138.40M | 145.59M | 150.92M |
| EBITDA | 3.40B | 3.40B | 4.79B | 4.51B | 3.74B | 5.51B | 3.70B | 3.54B | 4.67B | 2.13B |
| Operating Margin | 2.09% | 2.18% | 3.77% | 4.09% | 3.79% | 6.46% | 4.92% | 5.45% | 7.93% | 3.20% |
| Net Margin | 92.00% | 102.00% | 2.34% | 3.02% | 3.53% | 4.36% | 4.17% | 2.96% | 4.55% | 113.00% |
This table shows 10 annual periods of Humana's income statement, from FY 2025 back to FY 2016, across 16 line items including revenue, operating expenses, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow HUM's reporting calendar. What is a income statement?